Cutting edge: the phosphoinositide 3-kinase p110 delta is critical for the function of CD4+CD25+Foxp3+ regulatory T cells - PubMed (original) (raw)
Cutting edge: the phosphoinositide 3-kinase p110 delta is critical for the function of CD4+CD25+Foxp3+ regulatory T cells
Daniel T Patton et al. J Immunol. 2006.
Abstract
CD4+CD25+Foxp3+ regulatory T cells (Tregs) contribute to the maintenance of peripheral tolerance by inhibiting the expansion and function of conventional T cells. Treg development and homeostasis are regulated by the Ag receptor, costimulatory receptors such as CD28 and CTLA-4, and cytokines such as IL-2, IL-10, and TGF-beta. Here we show that the proportions of Tregs in the spleen and lymph nodes of mice with inactive p110delta PI3K (p110deltaD910A/D910A) are reduced despite enhanced Treg selection in the thymus. p110deltaD910A/D910A CD4+CD25+Foxp3+ Tregs showed attenuated suppressor function in vitro and failed to secrete IL-10. In adoptive transfer experiments, p110deltaD910A/D910A T cells failed to protect against experimental colitis. The identification of p110delta as an intracellular signaling protein that regulates the activity of CD4+CD25+Foxp3+ Tregs may facilitate the further elucidation of the molecular mechanisms responsible for Treg-mediated suppression.
Similar articles
- Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
Wang DW, Zhou RB, Yao YM, Zhu XM, Yin YM, Zhao GJ, Dong N, Sheng ZY. Wang DW, et al. J Pharmacol Exp Ther. 2010 Dec;335(3):553-61. doi: 10.1124/jpet.110.169961. Epub 2010 Sep 15. J Pharmacol Exp Ther. 2010. PMID: 20843956 - [Proliferation of CD4+ CD25+ regulatory T cells of rat by different cytokines in vitro].
Wang ZH, Zhu JY, Li T, Leng XS. Wang ZH, et al. Zhonghua Yi Xue Za Zhi. 2008 Mar 25;88(12):844-7. Zhonghua Yi Xue Za Zhi. 2008. PMID: 18756991 Chinese. - Effects of interleukin 4 on CD25+CD4+ regulatory T cell function.
Maerten P, Shen C, Bullens DM, Van Assche G, Van Gool S, Geboes K, Rutgeerts P, Ceuppens JL. Maerten P, et al. J Autoimmun. 2005 Sep;25(2):112-20. doi: 10.1016/j.jaut.2005.04.001. Epub 2005 Jul 26. J Autoimmun. 2005. PMID: 16051465 - Cutting edge: regulatory T cells induce CD4+CD25-Foxp3- T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta.
Xu L, Kitani A, Fuss I, Strober W. Xu L, et al. J Immunol. 2007 Jun 1;178(11):6725-9. doi: 10.4049/jimmunol.178.11.6725. J Immunol. 2007. PMID: 17513718 - Outgrowth of CD4low/negCD25+ T cells with suppressor function in CD4+CD25+ T cell cultures upon polyclonal stimulation ex vivo.
Vogtenhuber C, O'Shaughnessy MJ, Vignali DA, Blazar BR. Vogtenhuber C, et al. J Immunol. 2008 Dec 15;181(12):8767-75. doi: 10.4049/jimmunol.181.12.8767. J Immunol. 2008. PMID: 19050298 Free PMC article.
Cited by
- A highly selective PI3Kδ inhibitor BGB-10188 shows superior preclinical anti-tumor activities and decreased on-target side effects on colon.
Yang X, Bai H, Yuan X, Yang X, Liu Y, Guo M, Hu N, Jiang B, Lian Z, Ma Z, Wang J, Sun X, Zhang T, Su D, Wu Y, Li J, Wang F, Wang Z, Wang L, Liu X, Song X. Yang X, et al. Neoplasia. 2024 Nov;57:101053. doi: 10.1016/j.neo.2024.101053. Epub 2024 Sep 10. Neoplasia. 2024. PMID: 39260132 Free PMC article. - Activated PI3Kδ specifically perturbs mouse Treg homeostasis and function leading to immune dysregulation.
Singh AK, Qureshah FA, Drow T, Hou B, Rawlings DJ. Singh AK, et al. bioRxiv [Preprint]. 2023 Dec 23:2023.12.21.569665. doi: 10.1101/2023.12.21.569665. bioRxiv. 2023. PMID: 38187650 Free PMC article. Updated. Preprint. - SUMOylation patterns and signature characterize the tumor microenvironment and predict prognosis in lung adenocarcinoma.
Chen Z, Yang J, Tang L, Sun X, Li Y, Sheng Z, Ding H, Xu C, Tong X, Zhao J. Chen Z, et al. Front Cell Dev Biol. 2023 Apr 13;11:1094588. doi: 10.3389/fcell.2023.1094588. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37123398 Free PMC article. - Severe COVID-19: Drugs and Clinical Trials.
Ceja-Gálvez HR, Renteria-Flores FI, Nicoletti F, Hernández-Bello J, Macedo-Ojeda G, Muñoz-Valle JF. Ceja-Gálvez HR, et al. J Clin Med. 2023 Apr 16;12(8):2893. doi: 10.3390/jcm12082893. J Clin Med. 2023. PMID: 37109231 Free PMC article. Review. - PHLPP Signaling in Immune Cells.
Lordén G, Lam AJ, Levings MK, Newton AC. Lordén G, et al. Curr Top Microbiol Immunol. 2022;436:117-143. doi: 10.1007/978-3-031-06566-8_5. Curr Top Microbiol Immunol. 2022. PMID: 36243842 Review.
Publication types
MeSH terms
Substances
Grants and funding
- BB/C505659/1/BB_/Biotechnology and Biological Sciences Research Council/United Kingdom
- G120/854/MRC_/Medical Research Council/United Kingdom
- WT_/Wellcome Trust/United Kingdom
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials